Collegium Pharmaceutical (COLL) IPO Opens Flat

Today's IPO for Collegium Pharmaceutical, Inc., (Nasdaq: COLL) opened for trading at $12 after pricing 5,800,000 shares of its common stock at a price to the public of $12.

Jefferies LLC and Piper Jaffray & Co. are acting as joint book-running managers. Wells Fargo Securities, LLC is acting as lead manager and Needham & Company, LLC is acting as co-manager in the proposed offering.

Collegium is a specialty pharmaceutical company focused on developing a portfolio of products that incorporate its patent-protected DETERx technology platform for the treatment of chronic pain. The DETERx oral drug delivery technology is designed to provide extended-release delivery, unique abuse-deterrent properties, and flexible dose administration options.

You May Also Be Interested In

• CopperTech Metals launches IPO roadshow on NYSE at $16-$18 per share
• Lime seeks up to $1.66 billion valuation in US IPO
• Definium Therapeutics Inc (DFTX) PT Raised to $50 at Needham